We are pleased to announce that our research project PANACEA/EVs (Potency Assay and Novel Avenues for Clinical Evaluation of AngioARC or derived EV-based Therapeutics) is awarded 1M EUR in funding.
Through this project, in collaboration with Cellin Technologies we will contribute to the advancement of potency assessment and clinical evaluation of EV-based therapeutics.
We use cookies to enhance your browsing experience, analyze site traffic, and personalize content. You can choose which cookies to accept. Privacy Policy
Choose which cookie categories you'd like to allow. You can change these preferences at any time.
Essential cookies required for the website to function. These cannot be disabled.
Help us understand how visitors interact with our website by collecting anonymous usage data.
Used to deliver relevant advertisements and track campaign effectiveness across websites.